Sean Hemingway
Company: Imvax
Job title: Chief Operating Officer
Seminars:
Goldspire™: Developing a Fast Turnaround Individualized Cancer Vaccinelike Immunotherapy to Reduce Manufacturing Time & Treat Patients Faster 4:00 pm
Creating an individualized treatment by whole tumor to overcome heterogeneity with the most comprehensive antigens Reducing the personalized cancer vaccine timeline by central manufacturing and optimized logistics Ensuring cGMP cancer vaccine process consistency and quality by using a central manufacture site for alignment with the FDARead more
day: Pre-Conference Focus Day